Qing Song Health CoLtd delivered a strong Q4 2024 top-line result, marking a notable year-over-year revenue expansion and a materially higher gross profit, supported by an improved operating position. Revenue for QQ4 2024 reached 509.206 million TWD, up 121.0% YoY and 100.0% QoQ, while gross profit rose to 67.232 million TWD (gross margin ~13.20%). The company generated EBITDA of 99.646 million and net income of 15.306 million, translating to an EPS of 0.26 TWD for the quarter. However, cash generation remained challenging: operating cash flow was negative at -21.484 million, with free cash flow printed at -64.13 million due to significant working capital movements and ongoing capital expenditure of 42.646 million TWD. The balance sheet shows a high debt load (total debt of 1,123.818 million TWD; net debt of 837.789 million TWD) and a leverage profile that constrains near-term financial flexibility, even as liquidity avenues exist with cash and short-term investments totaling ~411.038 million TWD. Management commentary is not provided in the data set, so the narrative relies on reported results and segment/jurisdiction context. Going forward, the firm faces the typical long-term care sector dynamics in Taiwan, including aging population trends and wage/operating costs, but also opportunities from potential occupancy gains, program mix optimization, and potential regulatory or reimbursement changes that could alter margins and cash flow dynamics.